Not all scars are created equal. That's the conclusion of a new study by Weizmann Institute of Science researchers: They found that two distinct types of scars, referred to as "hot" and "cold," can ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

A key process in atherosclerosis is the endothelial-to-mesenchymal transition (EndMT), which involves the transformation of endothelial cells into mesenchymal cells, contributing to plaque ...

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...

India’s preeminent cardiac surgeon K.M. Cherian, who performed India’s first coronary bypass surgery, died in Bengaluru on Saturday (January 25, 2025). Only a couple of days ago his biography ...

Myocardial fibrosis is a key process for heart failure development that may lead to severe phenotypes, including cardiac ...

BENGALURU: India has lost its "Big Daddy" of cardiac surgery. Dr K. M. Cherian, the man whose hands restored hope and whose scalpel rewrote the history of heart care, breathed his last in Bengaluru.

Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and extracellular matrix ...